Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
癌症中染色质的时空组织和信息传递
基本信息
- 批准号:9070573
- 负责人:
- 金额:$ 207.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-19 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvocateAreaBasic ScienceBiological ModelsBiologyCancer BiologyCancer ControlCancer ModelCell NucleusCellular biologyChemicalsChemistryChicagoChromatinChromatin StructureChromosomesClinicalCollaborationsCommunicationCommunitiesComprehensive Cancer CenterComputer SimulationCore FacilityCouplesDNA PackagingDataDiagnosticEducation and OutreachEducational ActivitiesEducational workshopEngineeringEnsureEnvironmentEpigenetic ProcessFacultyFosteringFundingFunding MechanismsGene ExpressionGenesGeneticGenetically Engineered MouseGoalsHematologic NeoplasmsHumanImaging technologyInstitutesIonsKnowledgeLeadershipLengthLifeMalignant NeoplasmsMeasuresMechanicsMethodsModelingMolecularMutationNuclearNuclear StructureOutcomePatientsPhysicsPhysiologicalPlant RootsProcessRecording of previous eventsRegulatory PathwayResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResolutionResource AllocationResource SharingResourcesRoleScienceScientistTechniquesTechnologyTestingTherapeuticTherapeutic InterventionTranslationsWorkXenograft Modelanticancer researchbasecancer cellcell fixingcohesincondensindata integrationdata modelingdesignfrontierhigh rewardhigh riskimaging modalityin vitro Modelin vivoinnovationinsightinstrumentationinterestmeetingsmemberneoplastic cellnext generationnoveloncologyoutreachoutreach programphysical scienceprogramspublic health relevancetheoriesthree dimensional structuretooltraining opportunitytumorweb site
项目摘要
DESCRIPTION (provided by applicant): This application is organized around the framework of "Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer". The organizing framework of the CR-PSOC integrates the strengths of chemistry, genetics, and physics to address chromatin dynamics in cancer. Through the use of shared model systems Center investigators will be able to integrate data from across projects to develop a new conceptual understanding of the mechanisms underlying physical rearrangement of chromatin in cancer and how that controls gene expression. The Center is composed of three interrelated project areas, each focused on different aspects of chromatin structure and function. Each project integrates emerging physical science approaches and molecular and cancer cell biology tools, as well as theory and modeling methods from the physical sciences, to achieve a quantitative and predictive understanding of the of deregulation of chromatin mechanics, epigenetic regulatory pathways, gene expression, and the nuclear environment in cancer. The Center's projects maintain a clear cancer focus rooted in understanding the molecular mechanism behind genetic alterations in chromatin regulators in cancer, particularly hematological malignancy. The scientific activities of the CR-PSOC will be supported by two shared resource cores: the Nanocytometry Core and the PDX Human Tumor Model Core. These cores will encompass unique resources that will not only benefit CR-PSOC investigators but will substantially augment the tools and approaches of investigators across the PSON. The proposed Chicago Region-Physical Science Oncology Center (CR-PSOC) brings together a unique constellation of physical science, chemical biology, and genetics expertise and couples this expertise with cutting edge analytical instrumentation, specialized sequencing technology, super high resolution imaging modalities, and novel cancer model systems. This combination of expertise and resources will enable Center investigators and members of the PSO Network to examine the structural and functional aspects of chromatin and nuclear dynamics in cancer at unprecedented depth and breadth. The CR-PSOC will provide a range of educational activities and programs designed to stimulate the interest and enhance the capabilities of the next generation of researchers working at the frontiers of physical science and oncology. Through integration of a patient advocate into Center administration with a key role in advising and supporting the translation of CR-PSOC discoveries the Center will maintain a steady focus on the importance of targeting clinical outcomes through advances in basic research.
描述(申请人提供):这项申请是围绕着“染色质时空组织与癌症信息传递”的框架进行组织的。CR-PSOC的组织框架整合了化学、遗传学和物理学的优势,以解决癌症中的染色质动力学问题。通过使用共享模型系统,中心的研究人员将能够整合来自不同项目的数据,以对癌症中染色质物理重排的潜在机制以及如何控制基因表达产生新的概念性理解。该中心由三个相互关联的项目领域组成,每个领域都侧重于染色质结构和功能的不同方面。每个项目都结合了新兴的物理科学方法和分子和癌细胞生物学工具,以及物理科学的理论和建模方法,以实现对染色质机制、表观遗传调控途径、基因表达和癌症核环境的放松调控的定量和预测性了解。该中心的项目保持了明确的癌症重点,植根于了解癌症,特别是血液恶性肿瘤中染色质调节基因变化背后的分子机制。CR-PSOC的科学活动将得到两个共享资源核心的支持:纳米细胞测量核心和PDX人类肿瘤模型核心。这些核心将包含独特的资源,这些资源不仅将使CR-PSOC调查员受益,而且将大大增强整个PSON调查员的工具和方法。拟建的芝加哥地区-物理科学肿瘤学中心(CR-PSOC)汇集了物理科学、化学生物学和遗传学专业知识,并将这些专业知识与尖端分析仪器、专业测序技术、超高分辨率成像方式和新型癌症模型系统结合在一起。这种专业知识和资源的结合将使中心研究人员和PSO网络的成员能够以前所未有的深度和广度研究癌症中染色质和核动力学的结构和功能方面。CR-PSOC将提供一系列旨在激发在物理科学和肿瘤学前沿工作的下一代研究人员的兴趣和能力的教育活动和计划。通过将患者倡导者整合到中心管理中,并在建议和支持CR-PSOC发现的转换方面发挥关键作用,中心将稳定地关注通过基础研究的进步来确定临床结果的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan D. Licht其他文献
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
肿瘤抑制因子 BRCA1 对细胞周期的抑制需要 CDK 抑制剂 p21WAF1/CiP1
- DOI:
10.1038/38291 - 发表时间:
1997-09-11 - 期刊:
- 影响因子:48.500
- 作者:
Kumaravel Somasundaram;Hongbing Zhang;Yi-Xin Zeng;Yariv Houvras;Yi Peng;Hongxiang Zhang;Gen Sheng Wu;Jonathan D. Licht;Barbara L. Weber;Wafik S. El-Deiry - 通讯作者:
Wafik S. El-Deiry
HLA-DR, CD33<sup>+</sup>, CD56<sup>+</sup>, CD16<sup>-</sup> Myeloid/Natural Killer Cell Acute Leukemia: A Previously Unrecognized Form of Acute Leukemia Potentially Misdiagnosed as French-American-British Acute Myeloid Leukemia-M3
- DOI:
10.1182/blood.v84.1.244.244 - 发表时间:
1994-07-01 - 期刊:
- 影响因子:
- 作者:
Amy A. Scott;David R. Head;Kenneth J. Kopecky;Frederick R. Appelbaum;Karl S. Theil;Michael R. Grever;l-Ming Chen;Michael H. Whittaker;Barbara B. Griffith;Jonathan D. Licht;Samuel Waxman;Margaret M. Whalen;Arthur D. Bankhurst;Lynn C. Richter;Thomas M. Grogan;Cheryl L. Willman - 通讯作者:
Cheryl L. Willman
Compound Loss of <em>Dnmt3a</em> and <em>Kmt2c</em> in Myeloid Malignancies
- DOI:
10.1182/blood-2023-189411 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Prabhjot Kaur;Cassandra Berntsen;James Leonard;Daniil Shabashvili;Qingchen Yuan;Bowen Yan;Richard Lynn Bennett;Alberto Riva;Jonathan D. Licht;Olga A. Guryanova - 通讯作者:
Olga A. Guryanova
Synergistic Effect of Trifluridine and PARPi Combination in Targeting <em>TP53</em>-Mutated AML
- DOI:
10.1182/blood-2024-201781 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Phani Krishna Parcha;Vivek M. Shastri;Jonathan D. Licht;Jatinder K. Lamba - 通讯作者:
Jatinder K. Lamba
Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine.
Sprouty1 通过其 N 端酪氨酸控制泌尿生殖系统的发育。
- DOI:
10.1681/asn.2018111085 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
M. Vaquero;S. Cuesta;C. Anerillas;Gisela Altés;J. Ribera;M. Albert Basson;Jonathan D. Licht;J. Egea;M. Encinas - 通讯作者:
M. Encinas
Jonathan D. Licht的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan D. Licht', 18)}}的其他基金
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
探索 T 细胞急性淋巴细胞白血病中的 microRNA 降解
- 批准号:
10717486 - 财政年份:2023
- 资助金额:
$ 207.45万 - 项目类别:
UF Health Cancer Center Support Grant - Training Navigator Supplement
佛罗里达大学健康癌症中心支持补助金 - 培训导航补充
- 批准号:
10892335 - 财政年份:2023
- 资助金额:
$ 207.45万 - 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
- 批准号:
10625750 - 财政年份:2023
- 资助金额:
$ 207.45万 - 项目类别:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
定义和针对黑色素瘤中表观遗传可塑性驱动的耐药性和免疫逃逸
- 批准号:
10666665 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
KDM6A mutation as an epigenetic driver of multiple myeloma
KDM6A 突变作为多发性骨髓瘤的表观遗传驱动因素
- 批准号:
10229675 - 财政年份:2020
- 资助金额:
$ 207.45万 - 项目类别:
2019 Cancer Genetics and Epigenetics GRC/GRS
2019年癌症遗传学和表观遗传学GRC/GRS
- 批准号:
9754282 - 财政年份:2019
- 资助金额:
$ 207.45万 - 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
- 批准号:
9330809 - 财政年份:2016
- 资助金额:
$ 207.45万 - 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
- 批准号:
9759647 - 财政年份:2016
- 资助金额:
$ 207.45万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 207.45万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 207.45万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 207.45万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 207.45万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 207.45万 - 项目类别: